beloderm 0.5 mg/1 g mast
farmavita d.o.o. sarajevo - betamethasone - mast - 0.5 mg/1 g
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - ostali lijekovi protiv živčanog sustava - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
beloderm 0.5 mg/1 g mast
farmavita d.o.o. sarajevo - betamethasone - mast - 0.5 mg/1 g - 1 g masti sadrži: 0,5 mg betametazon (u obliku betametazon dipropionata)
beloderm 0.5 mg/1 g krema
farmavita d.o.o. sarajevo - betamethasone - krema - 0.5 mg/1 g - 1 g kreme sadrži: 0,5 mg betametazon (u obliku betametazon dipropionata)
beloderm 0.5 mg/1 g krema
farmavita d.o.o. sarajevo - betamethasone - krema - 0.5 mg/1 g - 1 g kreme sadrži: 0,5 mg betametazon (u obliku betametazon dipropionata)
beloderm 0.5 mg/1 g mast
farmavita d.o.o. sarajevo - betamethasone - mast - 0.5 mg/1 g - 1 g masti sadrži: 0,5 mg betametazona (u obliku betametazon dipropionata)
beloderm 0.5mg/g krem
"evropa lek pharma" doo podgorica - betametazon - krem - 0.5mg/g
beloderm 0.5mg/g mast
"evropa lek pharma" doo podgorica - betametazon - mast - 0.5mg/g
ecalta
pfizer europe ma eeig - anidulafungin - kandidijaza - antimikotika za sustavnu uporabu - liječenje od invazivnog kandidijaze kod odraslih i pedijatrijska bolesnika u dobi od 1 mjeseca do < 18 godina.